108
Participants
Start Date
July 15, 2019
Primary Completion Date
May 30, 2024
Study Completion Date
June 30, 2026
HLX10
HLX10 developed by our company is sterile intravenous injection, with specification of 100 mg/10 mL/bottle. The main ingredient is 10.0 mg/mL of recombinant humanized anti-PD-1 monoclonal antibody. The excipients include 0.95 mg/mL citric acid (citric acid monohydrate), 4.56 mg/mL sodium citrate (sodium citrate dihydrate), 3.0 mg/mL sodium chloride, 30.0 mg/mL mannitol and 0.20 mg/mL polysorbate 80 (tween 80), with pH of 5.5.
RECRUITING
the 900th Hospital of Joint Logistic Support Force, Fuzhou
RECRUITING
Peking University International Hospital, Beijing
RECRUITING
Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang
RECRUITING
The Second Affiliated Hospital of Dalian Medical University, Dalian
RECRUITING
Harbin Medical University Cancer Hospital,, Harbin
RECRUITING
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
Shanghai East Hospital, Shanghai
RECRUITING
Qinhuai Medical District, General Hospital of the eastern theater of the Chinese people's Liberation Army, Nanjing
RECRUITING
The Second Affiliated Hospital of Anhui Medical University, Hefei
RECRUITING
Qilu Hospital of Shandong University, Jinan
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
Tianjin Medical University Cancer Institue and Hospital, Tianjin
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
Taizhou first people's Hospital, Taizhou
RECRUITING
The First Affiliated Hospital of Xiamen University, Xiamen
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
The Third Xiangya Hospital, Central South University, Changsha
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
Zhongnan Hospital of Wuhan University, Wuhan
RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
The First Affiliated Hospital and Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
The First Affiliated Hospital (School of Clinical Medicine), Guangdong Pharmaceutical University, Guangzhou
RECRUITING
Affiliated Cancer Hospital & Institute, Guangzhou Medical University, Guangzhou
RECRUITING
Affiliated Hospital of Guangdong Medical University, Zhenjiang
RECRUITING
The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai
RECRUITING
First People's Hospital of Fushan, Fushan
RECRUITING
Zhongshan city People's Hospital, Zhongshan
RECRUITING
The People's Hospital of Guangxi Zhuangzu Autonomous Region, Nanning
RECRUITING
Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu
RECRUITING
West China Hospital, Sichuan University, Chengdu
RECRUITING
Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Center, Kunming
RECRUITING
the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
Fourth Hospital of Hebei Medical University,, Shijiazhuang
Shanghai Henlius Biotech
INDUSTRY